These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 34937590)

  • 21. Rhythmic low-field magnetic stimulation may improve depression by increasing brain-derived neurotrophic factor.
    Xiao L; Correll CU; Feng L; Xiang YT; Feng Y; Hu CQ; Li R; Wang G
    CNS Spectr; 2019 Jun; 24(3):313-321. PubMed ID: 29460712
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Youth Depression Alleviation with Anti-inflammatory Agents (YoDA-A): a randomised clinical trial of rosuvastatin and aspirin.
    Berk M; Mohebbi M; Dean OM; Cotton SM; Chanen AM; Dodd S; Ratheesh A; Amminger GP; Phelan M; Weller A; Mackinnon A; Giorlando F; Baird S; Incerti L; Brodie RE; Ferguson NO; Rice S; Schäfer MR; Mullen E; Hetrick S; Kerr M; Harrigan SM; Quinn AL; Mazza C; McGorry P; Davey CG
    BMC Med; 2020 Jan; 18(1):16. PubMed ID: 31948461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exploring Clinical Subgroups of Participants with Major Depressive Disorder that may Benefit from Adjunctive Minocycline Treatment.
    Anmella G; Meehan A; Ashton M; Mohebbi M; Fico G; Ng CH; Maes M; Berk L; De Prisco M; Singh AB; Malhi GS; Berk M; Dodd S; Hidalgo-Mazzei D; Grande I; Pacchiarotti I; Murru A; Vieta E; Dean OM
    Clin Psychopharmacol Neurosci; 2024 Feb; 22(1):33-44. PubMed ID: 38247410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Zinc monotherapy increases serum brain-derived neurotrophic factor (BDNF) levels and decreases depressive symptoms in overweight or obese subjects: a double-blind, randomized, placebo-controlled trial.
    Solati Z; Jazayeri S; Tehrani-Doost M; Mahmoodianfard S; Gohari MR
    Nutr Neurosci; 2015 May; 18(4):162-8. PubMed ID: 24621065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adjunctive minocycline for major mental disorders: A systematic review.
    Zheng W; Zhu XM; Zhang QE; Cheng G; Cai DB; He J; Ng CH; Ungvari GS; Peng XJ; Ning YP; Xiang YT
    J Psychopharmacol; 2019 Oct; 33(10):1215-1226. PubMed ID: 31294649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mediator effects of parameters of inflammation and neurogenesis from a N-acetyl cysteine clinical-trial for bipolar depression.
    Panizzutti B; Bortolasci C; Hasebe K; Kidnapillai S; Gray L; Walder K; Berk M; Mohebbi M; Dodd S; Gama C; Magalhães PV; Cotton SM; Kapczinski F; Bush AI; Malhi GS; Dean OM
    Acta Neuropsychiatr; 2018 Dec; 30(6):334-341. PubMed ID: 30008280
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Both Serum Brain-Derived Neurotrophic Factor and Interleukin-6 Levels Are Not Associated with Therapeutic Response to Lamotrigine Augmentation Therapy in Treatment-Resistant Depressive Disorder.
    Kagawa S; Mihara K; Suzuki T; Nagai G; Nakamura A; Nemoto K; Kondo T
    Neuropsychobiology; 2017; 75(3):145-150. PubMed ID: 29332095
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of macular xanthophyll supplementation on brain-derived neurotrophic factor, pro-inflammatory cytokines, and cognitive performance.
    Stringham NT; Holmes PV; Stringham JM
    Physiol Behav; 2019 Nov; 211():112650. PubMed ID: 31425700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improvements in quality of life with desvenlafaxine 50mg/d vs placebo in employed adults with major depressive disorder.
    Endicott J; Lam RW; Hsu MA; Fayyad R; Boucher M; Guico-Pabia CJ
    J Affect Disord; 2014 Sep; 166():307-14. PubMed ID: 25012446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IL-1β and BDNF are associated with improvement in hypersomnia but not insomnia following exercise in major depressive disorder.
    Rethorst CD; Greer TL; Toups MS; Bernstein I; Carmody TJ; Trivedi MH
    Transl Psychiatry; 2015 Aug; 5(8):e611. PubMed ID: 26241349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of escitalopram treatment on Quality of Life Enjoyment and Satisfaction Questionnaire scores in major depressive disorder and generalized anxiety disorder.
    Demyttenaere K; Andersen HF; Reines EH
    Int Clin Psychopharmacol; 2008 Sep; 23(5):276-86. PubMed ID: 18703937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of Agomelatine and Fluoxetine on HAM-D Score, Serum Brain-Derived Neurotrophic Factor, and Tumor Necrosis Factor-α Level in Patients With Major Depressive Disorder With Severe Depression.
    Gupta K; Gupta R; Bhatia MS; Tripathi AK; Gupta LK
    J Clin Pharmacol; 2017 Dec; 57(12):1519-1526. PubMed ID: 28833192
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A pilot, open-label, 8-week study evaluating the efficacy, safety and tolerability of adjunctive minocycline for the treatment of bipolar I/II depression.
    Soczynska JK; Kennedy SH; Alsuwaidan M; Mansur RB; Li M; McAndrews MP; Brietzke E; Woldeyohannes HO; Taylor VH; McIntyre RS
    Bipolar Disord; 2017 May; 19(3):198-213. PubMed ID: 28599348
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of inulin supplementation on inflammatory biomarkers and clinical symptoms of women with obesity and depression on a calorie-restricted diet: a randomised controlled clinical trial.
    Vaghef-Mehrabani E; Harouni R; Behrooz M; Ranjbar F; Asghari-Jafarabadi M; Ebrahimi-Mameghani M
    Br J Nutr; 2023 Jun; 129(11):1897-1907. PubMed ID: 36059088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum and plasma brain-derived neurotrophic factor and response in a randomized controlled trial of riluzole for treatment resistant depression.
    Wilkinson ST; Kiselycznyk C; Banasr M; Webler RD; Haile C; Mathew SJ
    J Affect Disord; 2018 Dec; 241():514-518. PubMed ID: 30153634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aripiprazole augmentation in major depressive disorder: a double-blind, placebo-controlled study in patients with inadequate response to antidepressants.
    Berman RM; Fava M; Thase ME; Trivedi MH; Swanink R; McQuade RD; Carson WH; Adson D; Taylor L; Hazel J; Marcus RN
    CNS Spectr; 2009 Apr; 14(4):197-206. PubMed ID: 19407731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Zishen pingchan granules combined with pramipexole on serum BDNF, IL-1β, IL-6, CRP, TNF-α levels in depressed patients with Parkinson's disease: Results of a randomized, double-blind, controlled study.
    Ning H; Zhou H; Yang N; Ren J; Wang H; Liu W; Zhao Y
    Exp Gerontol; 2023 Oct; 182():112295. PubMed ID: 37734668
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of once-daily extended release quetiapine fumarate (quetiapine XR) on quality of life and sleep in elderly patients with major depressive disorder.
    Locklear JC; Svedsäter H; Datto C; Endicott J
    J Affect Disord; 2013 Jul; 149(1-3):189-95. PubMed ID: 23639212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ratio of plasma BDNF to leptin levels are associated with treatment response in major depressive disorder but not in panic disorder: A 12-week follow-up study.
    An JH; Jang EH; Kim AY; Fava M; Mischoulon D; Papakostas GI; Na EJ; Jang J; Yu HY; Hong JP; Jeon HJ
    J Affect Disord; 2019 Dec; 259():349-354. PubMed ID: 31465895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Minocycline adjunctive treatment to risperidone for negative symptoms in schizophrenia: Association with pro-inflammatory cytokine levels.
    Zhang L; Zheng H; Wu R; Zhu F; Kosten TR; Zhang XY; Zhao J
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jul; 85():69-76. PubMed ID: 29678772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.